Table 1.

The proportions of the different sarcoma subtypes of all patients who underwent sarcoma excision from 2004 to 2014 in our University Hospital and of patients who answered life-quality quetionnaire. Subtypes were classified according to WHO classification

	All Patients n = 182	LQ-Patients n = 70
Liposarcoma	36 (20%)	16 (21%)
Well differentiated	21 (11,5%)	11 (16%)
De- differentiated	2 (1%)	2 (3%)
Myxoid	10 (5%)	2 (3%)
Pleomorph	3 (2%)	1 (1%)
Undifferentiated pleomorphic sarcoma	26 (14%)	7 (10%)
Synovial sarcoma	11 (6%)	5 (7%)
Fibroblastic/myofibroblastic sarcoma	43 (24%)	23 (30%)
Undifferentiated sarcoma	33 (18%)	9 (12%)
Leiomyosarcoma	13 (7%)	7 (9%)
Rhabdomyosarcoma	7 (4%)	2 (3%)
Extraskeletal chondro−/ osteosarcoma	5 (3%)	2 (3%)
Malignant peripheral nerve sheath tumor	4 (2%)	3 (4%)
Angiosarcoma	2 (1%)	0 (0%)
Other unclassified sarcoma	2 (1%)	1 (1%)